Freed From Pfizer, Capsugel May Find More Market Opportunities
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's divestiture of Capsugel moves the gelatin capsule manufacturer out from under pharma ownership, potentially opening a door to more business.